Executive Job Description | Growth Pharmaceutical Co.
High Visibility
Compensation Package to $170K
Plus Long Term Incentive Plan
This position is a highly visible Controllership position reporting to the CFO and will interact with the CEO as well. The principal responsibilities will include all the Accounting and Systems procedures for the various legal entities that make up the Global Division.
Key Responsibilities will Include:
• Ensure that all monthly, quarterly and yearly income statement, capital employed, cash flow and all supporting schedules for the legal entities are completed in accordance with US GAAP.
• Ensure day to day activities are being completed in accordance with US GAAP for all of the legal entities.
• Preparation of monthly, quarterly and yearly consolidated income statement, capital employed, cash flow and all supporting schedules for the legal entities to be completed in accordance with US GAAP.
• Ensure all year end-auditing schedules are prepared for all of the legal entities, final review with auditors regarding audit.
• For all of the legal entities insure that current procedures are reviewed and documented and adhered to both for actual activities as well as computer input both inside and outside the financial areas e.g. order taking, inventory control, invoice processing, outside warehousing, cash accounts.
• Management of working capital – for all of the legal entities to insure the proper utilization of cash, A/R levels are kept current, A/P payments, inventory levels are monitored, capital expenditures are written up and adhere to corporate policy of spending.
• Responsible for implementing and maintaining departmental operating policies in accordance with company standards and all government regulations.
Essential Requirements are as follows:
• CPA Required (Prefer some Big 4 experience)
• 8 to 12 years of Financial and accounting responsibilities.
• Solid knowledge of US GAAP, Consolidations
• Experience in dealing in a global manufacturing company.
Interviews are scheduled to begin the week of 10/17/11
|
